Safety and efficacy of neoadjuvant combination of hepatic artery infusion (HAI) of irinotecan, 5-fluorouracil, and oxaliplatin with intravenous (iv) cetuximab in patients with unresectable liver metastases from colorectal cancer (CRC): Interim report from OPTILIV—A European multicenter phase II trial.
M. Ducreux
No relevant relationships to disclose
P. Rougier
No relevant relationships to disclose
D. Smith
No relevant relationships to disclose
C. N. J. Focan
No relevant relationships to disclose
P. F. Innominato
No relevant relationships to disclose
M. Bouchahda
No relevant relationships to disclose
Y. Ajavon
No relevant relationships to disclose
D. Castaing
No relevant relationships to disclose
T. De Baere
No relevant relationships to disclose
A. Karaboué
No relevant relationships to disclose
C. Lepere
No relevant relationships to disclose
V. Boige
No relevant relationships to disclose
R. Adam
No relevant relationships to disclose
F. Levi
No relevant relationships to disclose